Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey.
Li C, Wang X, Wang L, Chen J, Zhang W, Pang Q, Zhao Y, Sun X, Zhang K, Li G, Li L, Qiao X, Liu M, Wang Y, Deng L, Wang W, Bi N, Zhang T, Deng W, Ni W, Chang X, Han W, Zhou Z, Liang J, Feng Q, Wang L, Chen D, Lv J, Zhu S, Han C, Xiao Z. Li C, et al. Among authors: deng l, deng w. Acta Oncol. 2021 May;60(5):627-634. doi: 10.1080/0284186X.2021.1902564. Epub 2021 Apr 1. Acta Oncol. 2021. PMID: 33793382
Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
Deng W, Yang J, Ni W, Li C, Chang X, Han W, Zhou Z, Chen D, Feng Q, Liang J, Lv J, Wang X, Wang X, Deng L, Wang W, Bi N, Zhang T, Li Y, Gao S, Xue Q, Mao Y, Sun K, Liu X, Fang D, Wang D, Li J, Zhao J, Shao K, Li Z, Chen X, Han L, Wang L, He J, Xiao Z. Deng W, et al. Among authors: deng l. Oncologist. 2020 Apr;25(4):e701-e708. doi: 10.1634/theoncologist.2019-0276. Epub 2020 Feb 21. Oncologist. 2020. PMID: 32083766 Free PMC article. Clinical Trial.
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
Gao LR, Wang X, Han W, Deng W, Li C, Wang X, Zhao Y, Ni W, Chang X, Zhou Z, Deng L, Wang W, Liu W, Liang J, Zhang T, Bi N, Wang J, Zhai Y, Feng Q, Lv J, Li L, Xiao Z. Gao LR, et al. Among authors: deng l, deng w. BMC Cancer. 2020 Sep 22;20(1):901. doi: 10.1186/s12885-020-07387-y. BMC Cancer. 2020. PMID: 32962674 Free PMC article. Clinical Trial.
Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis.
Chang X, Deng W, Ni W, Li C, Han W, Gao LR, Wang S, Zhou Z, Chen D, Feng Q, Bi N, Gao S, Lin Y, Chen J, Xiao Z. Chang X, et al. Among authors: deng w. Ann Surg Oncol. 2021 Nov;28(12):7076-7086. doi: 10.1245/s10434-021-10046-6. Epub 2021 May 9. Ann Surg Oncol. 2021. PMID: 33969465
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.
Chang X, Deng W, Wang X, Zhou Z, Yang J, Guo W, Liu M, Qi X, Li L, Zhang K, Zhang M, Shi Y, Liu K, Zhao Y, Wang H, Yu Z, Zhang J, Wang L, Qiao X, Han C, Zhu S, Zhang R, Chen J, Hu C, Zhang F, Hou X, Pang Q, Zhang W, Li G, Lin H, Sun X, Ge X, Li C, Ge H, Li D, Wang Y, Lu N, Gao X, Qin S, Tian Y, Xiao Z. Chang X, et al. Among authors: deng w. Radiat Oncol. 2021 Jun 9;16(1):102. doi: 10.1186/s13014-020-01691-4. Radiat Oncol. 2021. PMID: 34107984 Free PMC article.
A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis.
Deng W, Wang Q, Xiao Z, Tan L, Yang Z, Zhou Z, Zhang H, Chen D, Feng Q, Liang J, Li Y, He J, Gao S, Sun K, Cheng G, Liu X, Fang D, Xue Q, Mao Y, Wang D, Li J. Deng W, et al. Oncotarget. 2017 Jun 20;8(25):41102-41112. doi: 10.18632/oncotarget.17062. Oncotarget. 2017. PMID: 28456788 Free PMC article.
A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer.
Li C, Ni W, Wang X, Zhou Z, Deng W, Chang X, Chen D, Feng Q, Liang J, Wang X, Deng L, Wang W, Bi N, Zhang T, Xiao Z. Li C, et al. Among authors: deng l, deng w. Radiat Oncol. 2019 Mar 15;14(1):48. doi: 10.1186/s13014-019-1249-5. Radiat Oncol. 2019. PMID: 30876442 Free PMC article. Clinical Trial.
6,195 results